Lipophilicity in Peptide Chemistry and Peptide Drug Design

Lipophilicity in Drug Action and Toxicology

Volumn 4, Issue , 2008, Pages 355-373

  Fauchère, Jean Luc ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Central nervous system; Chromatography; Coefficients; Hydrophobic; Octanol

Indexed keywords

CHROMATOGRAPHY; HYDROPHOBIC CHROMATOGRAPHY;

CENTRAL NERVOUS SYSTEMS; COEFFICIENTS; HYDROPHOBIC; LIPOPHILICITY; OCTANOL; PEPTIDE CHEMISTRIES; PEPTIDE DRUGS;

PEPTIDES;

EID: 84958653862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527614998.ch20     Document Type: Chapter

References (98)

1. Tanford, C., The Hydrophobic Effect. Wiley: London, 1973
2. Rich, D., Effect of hydrophobic collapse on enzyme-inhibitor interactions: Implications for the design of peptidomimetics. In: Perspectives in Medicinal Chemistry. Testa, B., Kyburz, E., Fuhrer, W., and Giger, R. (Eds.). Helvetica Chimica Acta: Basel 15-25 (1993)
3. Van de Waterbeemd, H., Karajiannis, H., and El Tayar, N., Amino Acids 7, 129-145 (1994)
4. Fauchère, J. L., Do, K. Q., Jow, P. Y., and Hansch, C., Experientia 36, 1203-1204 (1980)
5. Yunger, L. M., and Cramer, R. D., Mol. Pharmacol. 20, 602-608 (1981)
6. Tsai, R. S., Testa, B., El Tayar, N., and Carrupt, P. A., J. Chem. Soc. Perkin Trans. 2, 1797-1802 (1991)
7. Pliška, V., Schmidt, M., and Fauchère, J. L., J. Chromatogr. 216, 79-92 (1981)
8. Molnar, I., and Horvath, C., J. Chromatogr. 142, 623-640 (1977)
9. Janin, J., Nature, 277, 491-492 (1979)
10. Ooi, T., Oobatake, M., Nemethy, G., and Scheraga, H. A., Proc. Natl. Acad. Sci. USA 84, 3086-3090 (1987)
11. Eisenberg, D., and McLachlan, A. D., Nature 319, 199-203 (1986)
12. Abraham, D. J., and Leo, A. J., Proteins, Struct. Funct. Gen. 2, 130-152 (1987)
13. Fauchère, J. L., and Pliška, V., Eur. J. Med. Chem. 18, 369-375 (1983)
14. Wynne, H. J., Van Buuren, K. H., and Wakelkamp, W., Experientia 38, 655-656 (1982)
15. Kim, A., and Szoka, F. C., Pharmaceut. Res. 9, 504-514 (1992)
16. Parker, J. M., Guo, D., and Hodges, R. S., Biochemistry 25, 5425-5432 (1986)
17. Roseman, M. A., J. Mol. Biol. 200, 513-522 (1988)
18. Kyte, J., and Doolittle, R. F., J. Mol. Biol. 157, 105-132 (1982)
19. Vallat, P., Gaillard, P., Carrupt, P. A., Tsai, R. S., and Testa, B., Helv. Chim. Acta 78, 471-485 (1995)
20. Purcell, W., Bass, G., and Clayton, J., Strategy of Drug Design, Appendix I, Wiley, New York, 1973
21. Rekker, R. F., and Mannhold, R., Calculation of Drug Lipophilicity, VCH: Weinheim, 1992
22. Bossé, R., Gerold, M., Fischli, W., Holck, M., and Escher, E., J. Cardiovasc. Pharmacol. 16 (Suppl. 4), S50-S55 (1990)
23. Paiva, A. C., Nouailhetes, V. L., and Paiva, T. B., J. Med. Chem. 20, 898-901 (1977)
24. El Tayar, N., Mark, A. E., Vallat, P., Brunne, R. M., Testa, B., and Van Gunsteren, W. F., J. Med. Chem. 36, 3757-3764 (1993)
25. Begley, D. J., Prog. Brain Res. 91, 163-169 (1992)
26. Banks, W. A., Kastin, A. J., Coy, D. H., and Angulo, E., Brain Res. Bull. 17, 155-158 (1986)
27. Paladino, J., Kucharczyk, N., Morris, A. D., Thibault, M., Mahieu, J. P., Serkiz, B., Volland, J. P., Autissier, C., and Fauchère, J. L., Drug Design Discov. 12, 121-128 (1994)
28. Clarke, F. H., and Cahoon, N. M., J. Pharm. Sci. 84, 53-54 (1995)
29. Banks, W. A., and Kastin, A. J., Brain Res. Bull. 15, 287-292 (1985)
30. Dodson, B. A., and Miller, K. W., Anesthesiology 62, 615-620 (1985)
31. Katayama, T., Nakao, K., Akamatsu, M., Ueno, T., and Fujita, T., J. Pharm. Sci. 83, 1357-1362 (1994)
32. Ohwaki, T., Ishii, M., Aoki, S., Tatsuishi, K., and Kayano, M., Chem. Pharm. Bull. 37, 3359-3362 (1989)
33. Veber, D. F., Saperstein, R., Nutt, R. F., Freidinger, R. M., Brady, S. F., Curley, P., Perlow, D. S., Paleveda, W. J., Colton, C. D., Zacchei, A. G., Tocco, D. J., Hoff, D. R., Gerich, G. E., and Hirschmann, R., Life Sci. 34, 1371-1378 (1984)
34. Bundgaard, H., and Moos, J., Pharmaceut. Res. 7, 885-892 (1990)
35. Kahns, A. H., Buur, A., and Bundgaard, H., Pharmaceut. Res. 10, 68-74 (1993)
36. Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., and Schölkens, B. A., Br. J. Pharmacol. 102, 769-773 (1991)
37. Thurieau, C., Félétou, M., Canet, E., and Fauchère, J. L., Bioorg. Med. Chem. Lett. 4, 781-784 (1994)
38. Scalbert, E., Narcisse, G., Abdon, D., Fauchère, J. L., and Santoni, J. P., J. Cardiovasc. Pharmacol. 15, 676-683 (1990)
39. Black, S. D., and Mould, D. R., Anal. Biochem. 193, 72-82 (1991)
40. Chikhale, E. G., Ka-Yun Ng, Burton, P. S., and Borchardt, R. T., Pharmaceut. Res. 11, 412-419 (1994)
41. Meek, J. L., and Rossetti, Z. L., J. Chromatogr. 211, 15-28 (1981)
42. Wilson, K. J., Honegger, A., Stoetzel, R. P., and Hughes, G. J., Biochem. J. 199, 31-41 (1981)
43. Mant, C. T., Burke, T. W., Black, J. A., and Hodges, R. S., J. Chromatogr. 458, 193-205 (1988)
44. Wilce, M. C., Aguilar, M. I., and Hearn, M. T., J. Chromatogr. 536, 165-183 (1991)
45. Guo, D., Mant, C. T., Taneja, A. K., Parker, J. M., and Hodges, R. S., J. Chromatogr. 359, 499-517 (1986)
46. Akamatsu, M., and Fujita, T., A new hydrophobicity index for amino acid side chains and its applications. In: Peptide Chemistry 1992, Yanainara, N. ed., Escom, Leiden (1993) p. 446-448
47. Akamatsu, M., Yoshida, Y., Nakamura, H., Asao, M., Iwamura, H. and Fujita, T., Quant. Struct.-Act. Relat. 8, 195-203 (1989)
48. Akamatsu, M., Okutani, S., Nakao, K., Hong, N. J., and Fujita, T., Quant. Struct.-Act. Relat. 9, 189-194 (1990)
49. Akamatsu, M., and Fujita, T., J. Pharm. Sci. 81, 164-174 (1992)
50. Gao, H., Lien, E. J., and Wang, F., J. Drug Target. 1, 59-66 (1993)
51. Leo, A. J., Computer calculation of peptide hydrophobicity. In: QSAR: Rational Approaches to the Design of Bioactive Compounds, Silipo, C., and Vittoria, A. eds., Elsevier, Amsterdam (1991) p. 349-352
52. Gavezzotti, A., J. Am. Chem. Soc. 105, 5220-5225 (1983)
53. Bodor, N., and Huang, M. J., J. Comput. Chem. 12, 1182-1186 (1991)
54. Funasaki, N., Hada, S., and Neya, S., Anal. Chem. 65, 1861-1867 (1993)
55. Van de Waterbeemd, H., Karajiannis, H., Kansy, M., Obrecht, D., Müller, K., and Lehmann, C., Conformation-lipophilicity relationships of peptides and peptide mimetics. In: QSAR and Computer Modeling in Drug Design. Sanz, F. (Ed.). Prous: Barcelona: 1995
56. Spatola, A. F., Peptide backbone modifications: A structure-activity analysis of peptides containing amide bond surrogates. In: Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, Vol. 7, Weinstein, B. ed., Dekker, New York (1983) p. 267-357
57. Fincham, I. F., Higginbottom, M., Hill, D. R., Horwell, D. C., O'Toole, J. C., Ratcliffe, G. S., Rees, D. C., and Roberts, E., J. Med. Chem. 35, 1472-1484 (1992)
58. Olson, G. L., Bolin, D. R., Bonner, M. P., Bös, M., Cook, C. M., Fry, D. C., Graves, B. J., Hatada, M., Hill, D. E., Kahn, M., Madison, V. S., Rusiecki, V. K., Sarabu, R., Sepinwall, J., Vincent, J. P., and Voss, M. E., J. Med. Chem. 36, 3039-3049 (1993)
59. Cho, C. Y., Moran, E. J., Cherry, S. R., Stephans, J. C., Fodor, S. P., Adams, C. L., Sunda-ram, A., Jacobs, J. W., and Schultz, P. G., Science 261, 1303-1305 (1993)
60. Attwood, M. R., Francis, R. J., Hassall, C. H., Krohn, A., Lawton, G., Natoff, I. L., Nixon, J., Redshaw, S., and Thomas, W. A., FEBS Lett. 165, 201-205 (1984)
61. Kahn, M., and Devens, B., Tetrahedron Lett. 27, 4841-4844 (1986)
62. Bondinell, W. E., Keenan, R. M., Miller, W. H., Ali, F. E., Allen, A. C, De Brosse, C. W., Eggleston, D. S., Erhard, K. F., Haltiwanger, R. C., and Yuan, C. K., Bioorg. Med. Chem. 2, 897-908 (1994)
63. Gante, J., Angew. Chem. Int. Ed. Engl. 33, 1699-1720 (1994)
64. Rose, G. D., Gierasch, L. M., and Smith, J. A., Adv. Protein Chem. 37, 1-109 (1985)
65. Freidinger, R. M., Schwenk, D., and Veber, D. F., J. Org. Chem. 47, 104-109 (1982)
66. Ward, P., Ewan, G. B., Jordan, C. C., Ireland, S. J., Hagan, R. M., and Brown, J. R., J. Med. Chem. 33, 1848-1851 (1990)
67. Smith, A. B., Hirschmann, R., Pasternak, A., Akaishi, R., Guzman, M. C., Jones, D. R., Keenan, T. P., and Sprengeler, P. A., J. Med. Chem. 37, 215-218 (1994)
68. Ma, S., Passaro, G., Rolland-Fulcrand, V., Fauchère, J. L., Lazaro, R., Roumestant, M. L., and Viallefont, P., Synthesis of γ-turn mimetics, In: Peptides 94, Proc. 23rd Eur. Peptide Symposium, Braga, 1995
69. Maia, H. L. (Ed.). ESCOM: Leiden 1996
70. Leo, A. J., Chem. Rev. 93, 1281-1306 (1993)
71. El Tayar, N., Karajiannis, H., and van de Waterbeemd, H., Amino Acids 8, 125-139 (1995)
72. Richards, N. G., Williams, P. B., and Tute, M. S., Int. J. Quantum Chem. 44, 219-233 (1992)
73. Büttner, K., Ostresh, J. M., and Houghten, R. A., Induced confromational effects during HPLC. In: Peptides, Chemistry, Structure and Biology. Rivier, J. E., and Marshall, G. (Eds.). Escom: Leiden; 423-425 (1990)
74. Schiffer, M., and Edmundson, A. B., Biophys. J. 7, 121-135 (1967)
75. Cornette, J. L., Cease, K. B., Margalit, H., Spouge, J. L., Berzofsky, J. A., and DeLisi, C., J. Mol. Biol. 195, 659-685 (1987)
76. Kaiser, E. T., Trends Biochem. Sci. 12, 305-309 (1987)
77. Stewart, J. M., Cann, J. R., Corey, M. J., Hahn, K. W., and Klis, W. A., Solid-phase synthesis of a peptide designed to have enzymatic activity. In: Solid Phase Synthesis 1992. Epton, R. (Ed.). Intercept: Andover; 23-27 (1992)
78. DeGrado, W. F., Wasserman, Z. R., and Lear, J. D., Science 243, 622-628 (1989)
79. Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., and Hoflack, J., Mol. Pharmacol. 40, 8-15 (1991)
80. Trumpp-Kallmeyer, S., Hoflack, J., and Hibert, M., Modeling of G-protein-coupled receptors: Application to the NK1 receptor: In: The Tachykinin Receptors. Buck, S. H. (Ed.). Humana Press: Totowa, NJ; 237-255 (1994)
81. Fesik, S. W., Gampe, R. T., Holzman, T. F., Egan, D. A., Edalji, R., Lulu, J. R., Simmer, R., Helfrich, R., Kishore, V., and Rich, D. H., Science 250, 1406-1409 (1990)
82. Wiley, R. A., and Rich, D. H., Med. Res. Revs. 13, 327-384 (1993)
83. Fauchère, J. L., Quarendon, P., and Kaetterer, L., J. Mol. Graphics 6, 202-206 (1988)
84. Gaillard, P., Carrupt, P. A., Testa, B., and Boudon, A., J. Comput.-Aid. Mol. Des. 8, 83-96 (1994)
85. Topliss, J. G., Perspect. Drug. Discov. Des. 1, 253-268 (1993)
86. Rosenberg, S. H., Spina, K. P., Woods, K. W., Polakowski, J., Martin, D. L., Yao, Z., Stein, H. H., Cohen, J., Barlow, J. R., Egan, D. A., Tricarico, K. A., Baker, W. R., and Kleinert, H. D., J. Med. Chem. 36, 449-459 (1993)
87. Conradi, R. A., Hilgers, A. R., Ho, N. F., and Burton, P. S., Pharmaceut. Res. 9, 435-439 (1992)
88. Burton, P. S., Conradi, R. A., and Hilgers, A. R., Adv. Drug Deliv. Rev. 7, 365-386 (1991)
89. Paterson, D. A., Conradi, R. A., Hilgers, A. R., Vidmar, T. J., and Burton, P. S., Quant. Struct.-Act. Relat. 13, 4-10 (1994)
90. Young, R. C., Mitchell, R. C., Brown, T. H., Ganellin, C. R., Griffiths, R., Jones, M., Rana, K. K., Saunders, D., Smith, I. R., Sore, N. E., and Wilks, T. J., J. Med. Chem. 31, 656-671 (1988)
91. El Tayar, N., Testa, B., and Carrupt, P. A., J. Phys. Chem. 96, 1455-1459 (1992)
92. Grevel, J., Transplant. Proc. (Suppl.) 18, 9-15 (1986)
93. Snider, R. M., Constantine, J. W., Lowe, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. D., Desai, M. C, Vinick, F. J., Spencer, R. W., and Hess, H. J., Science 251, 435-437 (1991)
94. Fauchère, J. L., Charton, M., Kier, L. B., Verloop, A., and Pliška, V., Int. J. Peptide Protein Res. 32, 269-278 (1988)
95. Muranishi, S., Sakai, A., Yamada, K., Murakami, M., Takada, K., and Kiso, Y., Pharmaceut. Res. 8, 649-652 (1991)
96. Albert, R., Marbach, P., Bauer, W., Briner, U., Fricker, G., Bruns, C. and Pless, J., Life Sci. 53, 517-525 (1993)
97. Bodor, N., Prokai, L., Wu, W. M., Farag, H., Jonalagadda, S., Kawamura, M., and Simkins, J., Science 257, 1698-1700 (1992)
98. Nomenclature and symbolism for amino acids and peptides, Eur. J. Biochem. 138, 1-37 (1984)